Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Karimi, Khalil ^a,b   Sarir, Hadi ^a   Mortaz, Esmaeil ^a   Smit, Joost J ^a   Hosseini, Hossein ^a   De Kimpe, Sjef J ^a   Nijkamp, Frans P ^a   Folkerts, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; CYTOKINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 8; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; CULTURE MEDIUM; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SMOKE;

ARTICLE; CELL ASSAY; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INFLAMMATION; LUNG EMPHYSEMA; LYMPHOCYTE; MACROPHAGE; MEDICAL RESEARCH; MONOCYTE; NEUTROPHIL; PATHOGENESIS; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECTS; METABOLISM; PHARMACOLOGY; PHYSIOLOGY; SMOKE; TOBACCO;

CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; INTERLEUKIN-8; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SMOKE; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOBACCO; TOLL-LIKE RECEPTOR 4;

EID: 33745483812     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-66     Document Type: Article

References (45)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001, 163(5):1256-1276.
2. Caramori G, Pandit A, Papi A: Is there a difference between chronic airway inflammation In chronic severe asthma and chronic obstructive pulmonary disease? Curr Opin Allergy Clin Immunol 2005, 5(1):77-83.
3. Di Stefano A. Caramori G, Ricciardolo FL, Capelli A, Adcock IM, Donner CF. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Clin Exp Allergy 2004, 34(8):1156-1167.
4. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(26):2645-2653.
5. Bohadana A, Teculescu D, Martinet Y: Mechanisms of chronic airway obstruction in smokers. Respir Med 2004, 98(2):139-151.
6. Sopori M: Effects of cigarette smoke on the immune system. Nat Rev Immunol 2002, 2(5):372-377.
7. Cazzola M, Dahl R: Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD. Chest 2004, 126(1):220-237.
8. Kim S, Nadel JA. Role of neutrophils in mucus hypersecretion in COPD and implications for therapy. Treat Respir Med 2004, 3(3):147-159.
9. Folkerts G, Nijkamp FP: Airway nitrergic pathways: is there therapeutic potential in asthma and COPD? Curr Opin Pharmacol 2004, 4(3):202-206.
10. Shapiro SD: The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160(5 Pt 2):S29-32.
11. Tetley TD: Macrophages and the pathogenesis of COPD. Chest 2002, 121 (5 Suppl): 156S-159S.
12. Vachier I, Vignola AM, Chiappara G, Bruno A, Meziane H, Godard P, Bousquet J, Chanez P: Inflammatory features of nasal mucosa in smokers with and without COPD. Thorax 2004, 59(4):303-307.
13. Linden M, Rasmussen JB, Piitulainen E, Tunek A, Larson M, Tegner H, Venge P, Laitinen LA, Brattsand R: Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993, 148(5):1226-1232.
14. Keatings VM, Collins PD, Scott DM, Barnes PJ: Differences in Interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996, 153(2):530-534.
15. Francus T, Romano PM, Manzo G, Fonacier L, Arango N, Szabo P: IL-I, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cell Immunol 1992, 145(1):156-174
16. Adachi Y, Mio T, Takigawa K, Striz I, Romberger DJ, Robbins RA, Spurzem JR, Heires P, Rennard SI: Mutual inhibition by TGF-beta and IL-4 in cultured human bronchial epithelial cells. Am J Physiol 1997, 273(3 Pt 1):L701-8.
17. Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ: Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 167(1):24-31.
18. Medzhitov R, Janeway CJ: The Toll receptor family and microbial recognition. Trends Microbiol 2000, 8(10):452-456.
19. Zarember KA, Godowski PJ: Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002, 168(2):554-561.
20. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL: Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999, 285(5428):732-736.
21. Cook DN, Pisetsky DS, Schwartz DA: Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004, 5(10):975-979.
22. Mohede IC, Van Ark I, Brons FM, Van Oosterhout AJ, Nijkamp FP: Salmeterol inhibits interferon-gamma and interleukin-4 production by human peripheral blood mononuclear cells. Int J Immunopharmacol 1996, 18(3):193-201.
23. Mandell GL, Coleman E: Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2001, 45(6):1794-1798.
24. Delneste Y, Charbonnier P, Herbault N, Magistrelli G, Caron G, Bonnefoy JY, Jeannin P: Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 2003, 101(1):143-150.
25. Wirtz HR, Schmidt M: Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. Eur Respir J 1996, 9(1):24-32.
26. Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ: Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002, 26(5):602-609.
27. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W: Bacterial endotoxin is an active component of cigarette smoke. Chest 1999, 115(3):829-835.
28. Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
29. Barton GM, Medzhitov R: Toll-like receptor signaling pathways. Science 2003, 300(5625):1524-1525.
30. Akira S: Mammalian Toll-like receptors. Curr Opin Immunol 2003, 15(1):5-11.
31. Morrison DC, Jacobs DM: Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 1976, 13(10):813-818.
32. Jacobs DM, Morrison DC: Stimulation of a T-independent primary anti-hapten response in vitro by TNP-lipopolysaccharide (TNP-LPS). J Immunol 1975, 114(1 Pt 2):360-364.
33. Pier GB, Markham RB, Eardley D: Correlation of the biologic responses of C3H/HEJ mice to endotoxin with the chemical and structural properties of the lipopolysaccharides from Pseudomonas aeruginosa and Escherichia coli. J Immunol 1981, 127(1):184-191.
34. Jones BW, Means TK, Heldwein KA, Keen MA, Hill PJ, Belisle JT, Fenton MJ: Different Toll-like receptor agonists induce distinct macrophage responses. J Leukoc Biol 2001, 69(6):1036-1044.
35. Chatila T, Silverman L, Miller R, Geha R: Mechanisms of T cell activation by the calcium ionophore ionomycin. J Immunol 1989, 143(4):1283-1289.
36. Foey AD, Brennan FM: Conventional protein kinase C and atypical protein kinase Czeta differentially regulate macrophage production of tumour necrosis factor-alpha and interleukin-10. Immunology 2004, 112(1):44-53.
37. Andreakos E, Sacre SM, Smith C, Lundberg A, Kiriakidis S, Stonehouse T, Monaco C, Feldmann M, Foxwell BM: Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/ TIRAP. Blood 2004, 103(6):2229-2237.
38. Grisham MB, Palombella VJ, Elliott PJ, Conner EM, Brand S, Wong HL, Pien C, Mazzola LM, Destree A, Parent L, Adams J: Inhibition of NFkappa B activation in vitro and in vivo: role of 26S proteasome. Methods Enzymol 1999, 300:345-363.
39. Weber WM, Hunsaker LA, Roybal CN, Bobrovnikova-Marjon EV, Abcouwer SF, Royer RE, Deck LM, Vander Jagt DL: Activation of NFkappaB is inhibited by curcumin and related enones. Bioorg Med Chem 2006, 14(7):2450-61.
40. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M: Multiple control of interleukin-8 gene expression. J Leukoc Biol 2002, 72(5):847-855.
41. Zhao Y, Usatyuk PV, Cummings R, Saatian B, He D, Watkins T, Morris A, Spannhake EW, Brindley DN, Natarajan V: Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. Biochem J 2005, 385(Pt 2):493-502.
42. Hayden MS, Ghosh S: Signaling to NF-kappaB. Genes Dev 2004, 18(18):2195-2224.
43. Sasaki CY, Barberi TJ, Ghosh P, Longo DL: Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem 2005, 280(41):34538-34547.
44. Ryan KA, Smith MFJ, Sanders MK, Ernst PB: Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect Immun 2004, 72(4):2123-2130.
45. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B: Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005, 6:68.